Toronto, ON (Nov. 3, 2025) \u2013 Manulife Canada is pleased to announce it is the first insurance company in Canada to offer access to GRAIL\u2019s Galleri\u00ae<\/sup> multi-cancer early detection test, to eligible life insurance customers, through its innovative Manulife Vitality<\/i> program.<\/p>\n Manulife has partnered with Medcan<\/a>, a global leader in proactive health and wellness services and the official Canadian provider of GRAIL\u2019s Galleri test. Through this collaboration, eligible Manulife customers will be able to access the test at Medcan\u2019s Toronto and Oakville clinics with support from Medcan\u2019s clinical team throughout the testing process \u2013 including pre-test counselling, results review, and next-step coordination.<\/p>\n This milestone advances Manulife\u2019s commitment to helping Canadians live longer, healthier, better lives by expanding access to emerging medical technologies. It also builds on the company\u2019s broader collaboration with GRAIL and continues to support the availability of innovative early cancer detection technologies.<\/p>\n \u201cManulife is proud to be at the forefront of innovation in Canadian insurance. By offering the Galleri test to eligible customers, we\u2019re expanding access to cutting-edge health solutions that can potentially improve outcomes through early detection,\u201d said Naveed Irshad, President and CEO, Manulife Canada. \u201cCancer has touched nearly every Canadian in some way. By offering this innovative screening tool, we\u2019re giving Canadians a stronger start in the fight \u2014 one rooted in early detection and proactive care.\u201d<\/p>\n \u201cWe\u2019re proud to collaborate with Manulife to introduce this groundbreaking screening test to their customers,\u201d said Shaun Francis, Chair and CEO of Medcan. \u201cAt Medcan, we offer best-in-class care supported by clinically validated innovations that pave the way for a healthier future. Being the first official provider to bring GRAIL\u2019s Galleri test to Canada directly aligns with our mission to empower individuals to take control of their health so they can live well, for life.\u201d<\/p>\n Cancer remains the leading cause of death in Canada, with two in five Canadians expected to be diagnosed with the disease over their lifetime. Early detection is critical \u2013 the five-year survival for the most commonly diagnosed cancers exceeds 90 per cent when caught at stage one.[1<\/a>]<\/sup> Despite advances in treatment, many cancers are still diagnosed at later stages, when options are more limited, and survival rates drop significantly.<\/p>\n Through a single blood draw, the Galleri test can detect more than 50 types of cancer before symptoms appear. With a clinical program involving more than 385,000 participants, the Galleri test is among the most rigorously studied multi-cancer early detection tests. In October, GRAIL released the initial findings<\/a> of PATHFINDER 2 \u2013 which also includes Canada\u2019s largest academic hospital network, University Health Network (UHN). The results showed that adding the Galleri test to recommended screenings for breast, cervical, colorectal and lung cancers increased cancer detection more than sevenfold.<\/p>\n These benefits build on the foundation provided by Canada\u2019s universal public healthcare system, which offers access to essential services, including well-established screening programs for several common cancers such as breast, cervical, colorectal, and lung. These programs play a vital role in early detection and improving outcomes for Canadians.<\/p>\n \u201cThis initiative is about looking ahead \u2013 exploring how we can responsibly expand access to promising technologies that have the potential to complement Canada\u2019s existing screening programs and support earlier detection,\u201d said Paul Savage, Head of Individual Insurance, Manulife Canada. \u201cWe\u2019re focused on how this offering can inform future solutions that empower Canadians to take proactive steps for their health.\u201d<\/p>\n The Galleri test will be offered at a reduced cost through the Manulife Vitality Plus<\/i><\/a> program and is available to eligible members aged 50+. The industry-leading Manulife Vitality <\/i>program is available across life insurance policies, pairing long-term financial protection with a health and wellness platform that rewards healthier choices linked to physical activity, nutrition, mindfulness and more.<\/p>\n This initiative also reflects Manulife\u2019s global efforts to explore innovative health solutions. The company\u2019s collaboration with GRAIL began in 2022 through its U.S. unit, John Hancock<\/a>, where the Galleri test is available to eligible life insurance customers and retirement plan participants. The Canadian initiative builds on this foundation, marking an important step in expanding access to services that help customers better understand and make more informed choices about their health.<\/p>\n This collaboration marks an important step in expanding access to innovative health technologies for Manulife customers. To learn more about Manulife Vitality<\/i>, visit Manulife.ca\/Vitality<\/a>.<\/p>\n 1. Statistics Canada.<\/a> Five-year cancer survival by stage at diagnosis in Canada<\/i>. Health Reports, January 18, 2023.<\/p>\n Manulife Financial Corporation (TSX\/NYSE\/PSE: MFC, SEHK: 945)<\/em> is a leading international financial services provider, helping people make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we provide financial advice and insurance, operating as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States. Through Manulife Investment Management, the global brand for our Global Wealth and Asset Management segment, we serve individuals, institutions, and retirement plan members worldwide. At the end of 2023, we had more than 38,000 employees, over 98,000 agents, and thousands of distribution partners, serving over 35 million customers. We trade as \u2018MFC\u2019 on the Toronto, New York, and the Philippine stock exchanges, and under \u2018945\u2019 in Hong Kong. For more information, visit www.manulife.com<\/a>.<\/p>\n Not all offerings are available in all jurisdictions. All figures in CAD unless otherwise stated.<\/p>\n Medcan is a global leader in proactive health and wellness services and is devoted to providing care for individuals, families and employers that is grounded in the latest evidence-based practices, technologies and treatments. Our team of medical experts unites to provide transformational specialty and primary care to achieve more for you and your health.<\/p>\n Located in downtown Toronto (150 York St.), Oakville (2275 Upper Middle Rd.), Collingwood (40 Huron St.), and Muskoka (seasonal \u2013 84 Joseph St.) Medcan is here to give you more control over your health and to help you live well, for life. For more information, visit medcan.com<\/a>.<\/p>\n SOURCE: Manulife Financial Corporation<\/em><\/p>\n Tags: health care<\/a>, industry first<\/a>, Manulife<\/a>, Vitality<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":" Manulife helping Canadians take proactive steps for their health through access to innovative technology Toronto, ON (Nov. 3, 2025) \u2013 Manulife Canada is pleased to announce it is the first insurance company in Canada...<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[1],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/24359"}],"collection":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/comments?post=24359"}],"version-history":[{"count":0,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/24359\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/media?parent=24359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/categories?post=24359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/tags?post=24359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Notes<\/h4>\n
About Manulife<\/b><\/h4>\n
About Medcan<\/b><\/h4>\n